Pediatric Brain Tumor Consortium Phase I Study of CD40 Agonist Sotigalimab in Pediatric and Young Adult Patients with Recurrent CNS Tumors and Newly Diagnosed DIPG
Year: 2026
Type: article
Study design: Clinical Trial
Source: Clinical Cancer Research
Authors: Holly B. Lindsay, Catherine A. Billups, Mehmet Kocak, Tyler J. Alban, Tina Young Poussaint, Phillip Wong, Timothy A. Chan, Benjamin Kovacic, Vladimir Makarov, Ivan Juric, C. Marcela Diaz-Montero, Raghvendra Srivastava, Paul Pavicic, Prerana Parthasarathy, Alicia Lenzen, Tobey J. MacDonald, Ian F. Pollack, Anna Vinitsky, Nathan J. Robison, Patricia Baxter, Eugene I. Hwang, Markos Leggas, Danny N. Khalil, Jason Fangusaro, Arzu Onar-Thomas, Ira J. Dunkel
Institutions: Children's Hospital Colorado, University of Colorado Anschutz, St. Jude Children's Research Hospital, Istanbul Medipol University, Cleveland Clinic, Case Western Reserve University, Boston Children's Hospital, Memorial Sloan Kettering Cancer Center, Northwestern University, Lurie Children's Hospital, Emory University, Aflac (United States), Children's Healthcare of Atlanta, Children's Hospital of Pittsburgh, Children's Hospital of Los Angeles, Baylor College of Medicine, Texas Children's Hospital, Children's National
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7166672319